Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Smart Microbeads for a revitalised Gut

Project description

Novel microbead therapy for gut disorders

The gut microbiota plays a crucial role in maintaining intestinal health, regulating immunity and supporting overall well-being. Microbiota disruptions alongside increased intestinal permeability and inflammation contribute to functional gastrointestinal disorders (FGIDs). With the support of the Marie Skłodowska-Curie Actions programme, the SMartGut project aims to develop a novel treatment that targets the root of FGID rather than just managing the symptoms. Researchers will develop probiotics encapsulated in innovative microbeads that consist of a biopolymer-based core and bioactive coating. These microbeads can deliver antioxidants and gut-targeting peptides to reduce inflammation and strengthen barrier function. The project team will employ simulated digestion models to evaluate the properties of the microbeads and their therapeutic potential, paving the way for a transformative FGID treatment.

Objective

Functional gastrointestinal disorders (FGIDs) are a group of debilitating conditions affecting up to 40% of the global population, significantly impairing quality of life and driving up healthcare costs. Current treatments focus on managing symptoms rather than addressing the root causes of FGIDs, such as inflammation, increased intestinal permeability, and gut microbiome disruptions.

The SMartGut project aims to develop innovative therapeutic microbeads that encapsulate probiotics within a photo-crosslinkable biopolymer-based core. To enhance functionality, SMartGut will employ the Layer-by-Layer assembly technique to create a nanoscale protective and bioactive coating on the therapeutic microbeads surface. This coating can incorporate antioxidants to reduce inflammation and improve probiotic adhesion in the gut, and targeted peptides to strengthen gut barrier function.

The therapeutic microbeads will be evaluated for their structural, morphological, and physico-chemical properties, followed by assessing the release kinetics of the bioactive components of the therapeutic microbeads and the survival of the encapsulated probiotic strains in the intestine using a simulated gastrointestinal digestion test designed for both healthy adults and the elderly. This test will ensure the effectiveness of the therapeutic microbeads in reducing gut inflammation, restoring the microbiome, and reinforcing intestinal epithelial junctions to address FGIDs. Then, the therapeutic microbeads will be incorporated into food models to evaluate their stability and impact on food characteristics while preserving their bioactivity features after food storage.

SMartGut has the potential to revolutionize FGID treatment by delivering a multifunctional therapeutic system that targets the core factors of these disorders. SMartGut promises significant scientific, societal, and economic impact by introducing a novel approach to FGID management and advancing the development of functional foods.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2024-PF-01

See all projects funded under this call

Coordinator

UNIVERSITAT POLITECNICA DE VALENCIA
Net EU contribution
€ 194 074,56
Address
CAMINO DE VERA SN EDIFICIO 3A
46022 Valencia
Spain
Region
Este Comunitat Valenciana Valencia/València
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data